Tokyo Tape
Sign in
← Soiken Holdings

Quarterly report · Q3

2385.TEDINET S100TEAA
Period2023-07-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥3.8bn2023-07-01 → 2024-03-31Cons.Net sales
Revenue¥8.1bn2022-07-01 → 2023-06-30Cons.Net sales (5-year summary)
Revenue¥6.6bn2022-07-01 → 2023-03-31Cons.Net sales
Operating income−¥560m2023-07-01 → 2024-03-31Cons.Operating income
Operating income¥785m2022-07-01 → 2023-03-31Cons.Operating income
Ordinary income−¥529m2023-07-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥727m2022-07-01 → 2023-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥785m2022-07-01 → 2023-03-31Cons.Ordinary income
Profit before tax−¥529m2023-07-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥784m2022-07-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)−¥575m2023-07-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥452m2022-07-01 → 2023-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥496m2022-07-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income−¥575m2023-07-01 → 2024-03-31Cons.Profit loss
Net income¥500m2022-07-01 → 2023-03-31Cons.Profit loss
Total assets¥7.0bnat 2024-03-31Cons.Assets
Total assets¥8.2bnat 2023-06-30Cons.Assets
Total assets¥8.7bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥641mat 2024-03-31Cons.Liabilities
Total liabilities¥1.1bnat 2023-06-30Cons.Liabilities
Net assets / equity¥6.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥7.2bnat 2023-06-30Cons.Net assets
Net assets / equity¥7.2bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥4.9bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥5.9bnat 2023-06-30Cons.Cash and deposits
EPS (basic)¥-21.962023-07-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-3.312024-01-01 → 2024-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.272022-07-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.972022-07-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.972023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio90.6%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.6%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio80.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 49
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-07-01 → 2024-03-31−¥17m
Reconciling Itemsreconcilingrevenue external2023-07-01 → 2024-03-31¥1m
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2024-03-31−¥19m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2024-03-31−¥225m
jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segmentrevenue2023-07-01 → 2024-03-31¥192m
jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2023-07-01 → 2024-03-31¥192m
jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2023-07-01 → 2024-03-31−¥51m
jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2023-07-01 → 2024-03-31¥982m
jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2023-07-01 → 2024-03-31¥982m
jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2023-07-01 → 2024-03-31−¥177m
jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segmentrevenue2023-07-01 → 2024-03-31¥1.9bn
jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segmentrevenue external2023-07-01 → 2024-03-31¥1.9bn
jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2023-07-01 → 2024-03-31¥6m
jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segmentsegment profit2023-07-01 → 2024-03-31−¥184m
jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segmentrevenue2023-07-01 → 2024-03-31¥255m
jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segmentrevenue external2023-07-01 → 2024-03-31¥242m
jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2023-07-01 → 2024-03-31¥13m
jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segmentsegment profit2023-07-01 → 2024-03-31−¥686,000
jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segmentrevenue2023-07-01 → 2024-03-31¥490m
jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segmentrevenue external2023-07-01 → 2024-03-31¥490m
jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segmentsegment profit2023-07-01 → 2024-03-31¥78m
—segment totalrevenue2023-07-01 → 2024-03-31¥3.9bn
—segment totalrevenue external2023-07-01 → 2024-03-31¥3.8bn
—segment totalrevenue intersegment2023-07-01 → 2024-03-31¥19m
—segment totalsegment profit2023-07-01 → 2024-03-31−¥336m
Reconciling Itemsreconcilingrevenue2022-07-01 → 2023-03-31−¥1m
Reconciling Itemsreconcilingrevenue external2022-07-01 → 2023-03-31¥1m
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2023-03-31−¥3m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2023-03-31−¥226m
jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segmentrevenue2022-07-01 → 2023-03-31¥404m
jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2022-07-01 → 2023-03-31¥404m
jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2022-07-01 → 2023-03-31¥68m
jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2022-07-01 → 2023-03-31¥3.4bn
jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2022-07-01 → 2023-03-31¥3.4bn
jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2022-07-01 → 2023-03-31¥701m
jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segmentrevenue2022-07-01 → 2023-03-31¥1.9bn
jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segmentrevenue external2022-07-01 → 2023-03-31¥1.9bn
jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segmentsegment profit2022-07-01 → 2023-03-31¥115m
jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segmentrevenue2022-07-01 → 2023-03-31¥382m
jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segmentrevenue external2022-07-01 → 2023-03-31¥380m
jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2022-07-01 → 2023-03-31¥3m
jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segmentsegment profit2022-07-01 → 2023-03-31¥43m
jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segmentrevenue2022-07-01 → 2023-03-31¥463m
jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segmentrevenue external2022-07-01 → 2023-03-31¥463m
jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segmentsegment profit2022-07-01 → 2023-03-31¥83m
—segment totalrevenue2022-07-01 → 2023-03-31¥6.6bn
—segment totalrevenue external2022-07-01 → 2023-03-31¥6.6bn
—segment totalrevenue intersegment2022-07-01 → 2023-03-31¥3m
—segment totalsegment profit2022-07-01 → 2023-03-31¥1.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 314
ItemContextValueUnit
Capital stockPrior1YearInstant1836587000JPY
Capital stockCurrentQuarterInstant1836587000JPY
Capital surplusPrior1YearInstant1899955000JPY
Capital surplusCurrentQuarterInstant1956966000JPY
Retained earningsPrior1YearInstant3232312000JPY
Retained earningsCurrentQuarterInstant2526989000JPY
Shareholders equityPrior1YearInstant6968855000JPY
Shareholders equityCurrentQuarterInstant6320542000JPY
Non controlling interestsPrior1YearInstant203362000JPY
Non controlling interestsCurrentQuarterInstant16480000JPY
Net assetsPrior1YearInstant7172217000JPY
Net assetsCurrentQuarterInstant6337023000JPY
Liabilities and net assetsPrior1YearInstant8239982000JPY
Liabilities and net assetsCurrentQuarterInstant6977552000JPY
Net salesPrior1YTDDuration6586192000JPY
Net salesCurrentYTDDuration3841269000JPY
Cost of salesPrior1YTDDuration3525303000JPY
Cost of salesCurrentYTDDuration2000973000JPY
Gross profitPrior1YTDDuration3060888000JPY
Gross profitCurrentYTDDuration1840296000JPY
Selling general and administrative expensesPrior1YTDDuration2276275000JPY
Selling general and administrative expensesCurrentYTDDuration2400616000JPY
Operating incomePrior1YTDDuration784613000JPY
Operating incomeCurrentYTDDuration-560320000JPY
Interest income noiPrior1YTDDuration284000JPY
Interest income noiCurrentYTDDuration55000JPY
Compensation income for damage noiPrior1YTDDuration255000JPY
Compensation income for damage noiCurrentYTDDuration29899000JPY
Other noiPrior1YTDDuration1053000JPY
Other noiCurrentYTDDuration3011000JPY
Non operating incomePrior1YTDDuration1593000JPY
Non operating incomeCurrentYTDDuration32966000JPY
Other noePrior1YTDDuration720000JPY
Other noeCurrentYTDDuration1833000JPY
Non operating expensesPrior1YTDDuration720000JPY
Non operating expensesCurrentYTDDuration1833000JPY
Ordinary incomePrior1YTDDuration785486000JPY
Ordinary incomeCurrentYTDDuration-529187000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration1887000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration－JPY
Loss on sales of noncurrent assets elPrior1YTDDuration－JPY
Loss on sales of noncurrent assets elCurrentYTDDuration134000JPY
Extraordinary lossPrior1YTDDuration1887000JPY
Extraordinary lossCurrentYTDDuration134000JPY
Income before income taxesPrior1YTDDuration783598000JPY
Income before income taxesCurrentYTDDuration-529322000JPY
Income taxes currentPrior1YTDDuration237521000JPY
Income taxes currentCurrentYTDDuration3072000JPY
Income taxes deferredPrior1YTDDuration45856000JPY
Income taxes deferredCurrentYTDDuration42746000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-06-30pass rounding
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-07-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-07-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass